Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Kapasi A, Meade BD, Plikaytis B, Pawloski L, Martin MD, Yoder S, Rock MT, Coddens S, Haezebroeck V, Fievet-Groyne F, Bixler G, Jones C, Hildreth S, Edwards KM, Messonnier NE, Tondella ML.

Clin Vaccine Immunol. 2012 Jan;19(1):64-72. doi: 10.1128/CVI.05460-11. Epub 2011 Nov 23.

2.

Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine.

Weston W, Messier M, Friedland LR, Wu X, Howe B.

Vaccine. 2011 Nov 3;29(47):8483-6. doi: 10.1016/j.vaccine.2011.09.063. Epub 2011 Sep 25.

PMID:
21945698
3.

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories.

Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH; EU Pertstrain group..

Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):307-12. doi: 10.1007/s10096-010-1104-y. Epub 2010 Nov 11. Review.

4.

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults.

Booy R, Van der Meeren O, Ng SP, Celzo F, Ramakrishnan G, Jacquet JM.

Vaccine. 2010 Dec 10;29(1):45-50. doi: 10.1016/j.vaccine.2010.10.025. Epub 2010 Oct 23.

PMID:
20974302
5.

Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH.

J Clin Microbiol. 2010 Dec;48(12):4459-63. doi: 10.1128/JCM.01371-10. Epub 2010 Oct 13.

6.

Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults.

Mertsola J, Van Der Meeren O, He Q, Linko-Parvinen A, Ramakrishnan G, Mannermaa L, Soila M, Pulkkinen M, Jacquet JM.

Clin Infect Dis. 2010 Sep 15;51(6):656-62. doi: 10.1086/655825.

PMID:
20704493
7.

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.

Dalby T, Petersen JW, Harboe ZB, Krogfelt KA.

J Med Microbiol. 2010 Sep;59(Pt 9):1029-36. doi: 10.1099/jmm.0.020826-0. Epub 2010 May 27.

PMID:
20508003
8.

Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Menzies SL, Kadwad V, Pawloski LC, Lin TL, Baughman AL, Martin M, Tondella ML, Meade BD; Pertussis Assay Working Group..

Clin Vaccine Immunol. 2009 Dec;16(12):1781-8. doi: 10.1128/CVI.00248-09. Epub 2009 Oct 28.

9.

Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control.

Kirkland KB, Talbot EA, Decker MD, Edwards KM.

Clin Infect Dis. 2009 Aug 15;49(4):584-7. doi: 10.1086/603555.

PMID:
19589084
10.

Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.

Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R.

Clin Vaccine Immunol. 2009 Mar;16(3):303-11. doi: 10.1128/CVI.00372-08. Epub 2008 Dec 24.

11.

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.

Tondella ML, Carlone GM, Messonnier N, Quinn CP, Meade BD, Burns DL, Cherry JD, Guiso N, Hewlett EL, Edwards KM, Xing D, Giammanco A, Wirsing von König CH, Han L, Hueston L, Robbins JB, Powell M, Mink CM, Poolman JT, Hildreth SW, Lynn F, Morris A.

Vaccine. 2009 Feb 5;27(6):803-14. doi: 10.1016/j.vaccine.2008.11.072. Epub 2008 Dec 9.

PMID:
19071179
12.

Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.

Rieber N, Graf A, Belohradsky BH, Hartl D, Urschel S, Riffelmann M, Wirsing von König CH, Liese J.

Vaccine. 2008 Dec 9;26(52):6929-35. doi: 10.1016/j.vaccine.2008.09.064. Epub 2008 Oct 11.

PMID:
18852002
13.

Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine.

Riffelmann M, Littmann M, Hülsse C, von König CH.

Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):275-9. doi: 10.1007/s10096-008-0625-0. Epub 2008 Sep 17.

PMID:
18797942
14.

Duration of humoral immunity to common viral and vaccine antigens.

Amanna IJ, Carlson NE, Slifka MK.

N Engl J Med. 2007 Nov 8;357(19):1903-15.

15.

Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine.

Fraser C, Tomassini JE, Xi L, Golm G, Watson M, Giuliano AR, Barr E, Ault KA.

Vaccine. 2007 May 22;25(21):4324-33. Epub 2007 Mar 12.

PMID:
17445955
16.

Immunity to pertussis 5 years after booster immunization during adolescence.

Edelman K, He Q, Mäkinen J, Sahlberg A, Haanperä M, Schuerman L, Wolter J, Mertsola J.

Clin Infect Dis. 2007 May 15;44(10):1271-7. Epub 2007 Apr 2.

PMID:
17443462
17.

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV; Centers for Disease Control and Prevention.; Advisory Committee on Immunization Practices.; Healthcare Infection Control Practices Advisory Committee..

MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.

18.

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP)..

MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.

19.

Characterization of serological responses to pertussis.

Watanabe M, Connelly B, Weiss AA.

Clin Vaccine Immunol. 2006 Mar;13(3):341-8.

20.

Supplemental Content

Support Center